These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26421409)

  • 21. Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?
    De Carolis S; Botta A; Salvi S; di Pasquo E; Del Sordo G; Garufi C; Lanzone A; De Carolis MP
    Autoimmun Rev; 2015 Sep; 14(9):760-2. PubMed ID: 25936295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study.
    Ruffatti A; Salvan E; Del Ross T; Gerosa M; Andreoli L; Maina A; Alijotas-Reig J; De Carolis S; Mekinian A; Bertero MT; Canti V; Brucato A; Bremme K; Ramoni V; Mosca M; Di Poi E; Caramaschi P; Galeazzi M; Tincani A; Trespidi L
    Thromb Haemost; 2014 Oct; 112(4):727-35. PubMed ID: 25008944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease.
    Erkan D; Unlu O; Sciascia S; Belmont HM; Branch DW; Cuadrado MJ; Gonzalez E; Knight JS; Uthman I; Willis R; Zhang Z; Wahl D; Zuily S; Tektonidou MG;
    Lupus; 2018 Mar; 27(3):399-406. PubMed ID: 28764618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.
    Nuri E; Taraborelli M; Andreoli L; Tonello M; Gerosa M; Calligaro A; Argolini LM; Kumar R; Pengo V; Meroni PL; Ruffatti A; Tincani A
    Immunol Res; 2017 Feb; 65(1):17-24. PubMed ID: 27406736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of hydroxychloroquine on antiphospholipid antibody-induced changes in first trimester trophoblast function.
    Albert CR; Schlesinger WJ; Viall CA; Mulla MJ; Brosens JJ; Chamley LW; Abrahams VM
    Am J Reprod Immunol; 2014 Feb; 71(2):154-64. PubMed ID: 24325143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiphospholipid syndrome: An update on risk factors for pregnancy outcome.
    De Carolis S; Tabacco S; Rizzo F; Giannini A; Botta A; Salvi S; Garufi C; Benedetti Panici P; Lanzone A
    Autoimmun Rev; 2018 Oct; 17(10):956-966. PubMed ID: 30118899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managing antiphospholipid syndrome in pregnancy.
    Schreiber K; Hunt BJ
    Thromb Res; 2019 Sep; 181 Suppl 1():S41-S46. PubMed ID: 31477227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Obstetrical APS: Is there a place for additional treatment to aspirin-heparin combination?].
    Mekinian A; Kayem G; Cohen J; Carbillon L; Abisror N; Josselin-Mahr L; Bornes M; Fain O
    Gynecol Obstet Fertil Senol; 2017 Jan; 45(1):37-42. PubMed ID: 28238314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study.
    Mekinian A; Alijotas-Reig J; Carrat F; Costedoat-Chalumeau N; Ruffatti A; Lazzaroni MG; Tabacco S; Maina A; Masseau A; Morel N; Esteve-Valverde EE; Ferrer-Oliveras R; Andreoli L; De Carolis S; Josselin-Mahr L; Abisror N; Nicaise-Roland P; Tincani A; Fain O;
    Autoimmun Rev; 2017 Jul; 16(7):730-734. PubMed ID: 28478081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study.
    Kravvariti E; Koutsogianni A; Samoli E; Sfikakis PP; Tektonidou MG
    Autoimmun Rev; 2020 Apr; 19(4):102491. PubMed ID: 32084592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of hydroxychloroquine on antiphospholipid antibodies-inhibited endometrial angiogenesis.
    Dong Y; Lu Y; Xia Y; Wang X
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7084-7092. PubMed ID: 34182874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study.
    Mekinian A; Lazzaroni MG; Kuzenko A; Alijotas-Reig J; Ruffatti A; Levy P; Canti V; Bremme K; Bezanahary H; Bertero T; Dhote R; Maurier F; Andreoli L; Benbara A; Tigazin A; Carbillon L; Nicaise-Roland P; Tincani A; Fain O;
    Autoimmun Rev; 2015 Jun; 14(6):498-502. PubMed ID: 25617818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management and outcomes of women with antiphospholipid syndrome during pregnancy.
    Tao JJ; Adurty S; D'Angelo D; DeSancho MT
    J Thromb Thrombolysis; 2023 May; 55(4):751-759. PubMed ID: 36967425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiphospholipid Syndrome and the Kidney.
    Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D
    Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive.
    Giles I; Rahman A
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):525-37. PubMed ID: 19591782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: A meta-analysis.
    Duan J; Ma D; Wen X; Guo Q; Gao J; Zhang G; Xu K; Zhang L
    Lupus; 2021 Jun; 30(7):1163-1174. PubMed ID: 33853420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
    Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of hydroxychloroquine in pregnancy and its effect on perinatal outcomes in a population with autoimmune abnormalities.
    Ye S; Zhao X; Liu Y; Ma Y; Wang Y; Zhao J
    Clin Rheumatol; 2023 Apr; 42(4):1137-1150. PubMed ID: 36507975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina.
    Garcia L; Velloso MS; Martire MV; Savy F; Arizpe F; Garcia N; Testi A; Pena C; Costi AC; Isnardi C; Capelusnik D; Mazza S; Curi YS; Collado V; Rodriguez MF; Scarafia S; Pisoni C; de la Torre M; Seewald A; Riva ME; Garcia M
    Lupus; 2020 Dec; 29(14):1866-1872. PubMed ID: 33028177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obstetrical APS: is there a place for hydroxychloroquine to improve the pregnancy outcome?
    Mekinian A; Costedoat-Chalumeau N; Masseau A; Tincani A; De Caroli S; Alijotas-Reig J; Ruffatti A; Ambrozic A; Botta A; Le Guern V; Fritsch-Stork R; Nicaise-Roland P; Carbonne B; Carbillon L; Fain O
    Autoimmun Rev; 2015 Jan; 14(1):23-9. PubMed ID: 25179813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.